Letter from AmeriKat: Will narrowing innovator-generic price gap change IP law? By Annsley Merelle Ward on Monday, March 16, 2015 AmeriKat cost of medicines economics of pharmaceutical IP generic drug applications generic pharma products hatch-waxman innovator IP market United States IP system +
IP as an Asset: Really? By Neil Wilkof on Friday, October 25, 2013 asset IP IP market IP valuation Neil Wilkof +